Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 18, 2006

Eli Lilly Amends Acquisition Price for ICOS to $2.3B

  • Eli Lilly and Company reached an agreement with ICOS to amend the merger agreement relating to the proposed acquisition of ICOS by Lilly. Under the revised terms, Lilly will acquire all of the outstanding shares of ICOS common stock at a price of $34 per share, for a total purchase price of approximately $2.3 billion.

    he proposed $34 price reflects a $2 per share increase from the $32 per share of the original merger agreement, and Lilly is affirming that this is its best and final offer.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »